Stevanato Group S.p.A (STVN) Gross Margin (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Gross Margin came in at 28.75% in Q2 2026, up 68.0% year-over-year from 17.11% in Q2 2025, and up 4.6% quarter-over-quarter from 27.48% in Q1 2026.
Analysis
Stevanato Group S.p.A (STVN) Gross Margin (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Gross Margin for 7 consecutive years, with 28.75% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Gross Margin rose 68.0% year-over-year to 28.75% in Q2 2026; TTM through Jun 2026 was 29.17%, a 113.0% increase from a year earlier, with the FY2025 full-year figure at 28.99%, up 160.0% from the prior year.
- Gross Margin was 28.75% for Q2 2026 at Stevanato Group S.p.A, up from 27.48% in the prior quarter.
- Over five years, Gross Margin peaked at 34.3% in Q4 2022 and troughed at 26.01% in Q2 2024.
- A 5-year average of 29.74% and a median of 30.12% in 2023 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin soared 292 bps in 2022 and slumped 569 bps in 2024, its largest moves.
- Over 5 years, Gross Margin stood at 34.3% in 2022, then decreased by 7 bps to 31.75% in 2023, then slipped by 6 bps to 29.7% in 2024, then advanced by 4 bps to 30.85% in 2025, then retreated by 7 bps to 28.75% in 2026.
- The last three Gross Margin figures came in at 28.75% (Q2 2026), 27.48% (Q1 2026), and 30.85% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 46.46% |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | 28.82% |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 37.74% |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 34.86% |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | 28.75% |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | 42.55% |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | 18.24% |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | 2.65% |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.75% |
| Mar 31, 2026 | 27.48% |
| Dec 31, 2025 | 30.85% |
| Sep 30, 2025 | 29.19% |
| Jun 30, 2025 | 28.06% |
| Mar 31, 2025 | 27.24% |
| Dec 31, 2024 | 29.70% |
| Sep 30, 2024 | 26.79% |
| Jun 30, 2024 | 26.01% |
| Mar 31, 2024 | 26.36% |
| Dec 31, 2023 | 31.75% |
| Sep 30, 2023 | 30.54% |
| Jun 30, 2023 | 30.91% |
| Mar 31, 2023 | 32.04% |
| Dec 31, 2022 | 34.30% |
| Sep 30, 2022 | 31.61% |
| Jun 30, 2022 | 31.83% |
| Mar 31, 2022 | 31.80% |
| Dec 31, 2021 | 31.38% |
| Sep 30, 2021 | 29.49% |